| abstract |
The present invention relates to a novel crystalline phase of (3S, 3S ') 4,4'-dithiodiylbis (3-aminobutane-1-sulfonic acid) (ABSD) and L-lysine, and more particularly The use in the pharmaceutical industry and its preparation method. The present invention also relates to a medicine comprising at least one crystalline phase of (3S, 3S ') 4,4'-dithiodiylbis (3-aminobutane-1-sulfonic acid) (ABSD) and L-lysine The composition and are related to the therapeutic or preventive use of the crystalline phase and a composition comprising the crystalline phase. |